Developer docs
API playgroundTry for free, no card

Search company profiles

Renaissance BioScience

Full company profile

uuid0000993

Namestring
Renaissance BioScience
Legal namestring
Renaissance BioScience Corp.
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Renaissance BioScience Corp. is a privately held Vancouver-based applied life sciences company founded in 2013 that develops proprietary yeast-based platform technologies for the food and beverage, agriculture, and specialty industrial markets. The company's core technology stack combines whole organism engineering (non-GMO classical breeding and adaptive evolution) with gene-targeted engineering (gene editing and molecular biology), and an integrated design layer that produces yeast strains unachievable through either approach alone. Commercial product lines include acrylamide-reducing baker's yeast (Acrylow/Acryleast, reducing acrylamide by up to 95%), H2S-preventing wine yeast strains (Vivace, Allegro, Andante, Maestoso, Brioso, Ossia Organic), selectively bred premium beer yeasts under the Bright Brewers Yeast subsidiary, a yeast-derived virus-like particle (VLP) platform for RNAi biopesticides, and a renewable bioplastics program in partnership with Biome Bioplastics.

Renaissance operates a licensing-led go-to-market model. The company monetizes its strains primarily through exclusive regional and global license agreements with major industry manufacturers and distributors — Angel Yeast for global wine, cider and craft beer; Orkla Food Ingredients for acrylamide-reducing yeast in Nordic, Baltic and Eastern European markets; Kerry for global food ingredients; Gusmer Enterprises for North America; and Quercus Europe for Spain — supplemented by direct sales through three wholly owned subsidiaries (Renaissance Yeast Inc., Renaissance Ingredients Inc., Bright Brewers Yeast Inc.) and non-dilutive R&D funding from Canadian and UK government programs including NRC IRAP, Mitacs, Genome BC, and Innovate UK. The company holds 16 patents on H2S-preventing yeast across major wine-producing jurisdictions plus granted patents on RNA production and delivery in China, Australia, and Mexico, with multiple provisional and PCT filings on acrylamide reduction and the VLP platform.

Commercially, Renaissance has product-market fit in three distinct verticals: food and beverage (acrylamide reduction for baked goods, snacks and coffee; H2S prevention in wine; quality and consistency in craft beer); agricultural technology (RNAi biopesticides for Colorado potato beetle, canola flea beetle, and a broader fungicide/herbicide roadmap); and emerging specialty markets including bioplastics and plant-based protein flavor solutions. Customers range from global ingredient majors (Kerry, Angel Yeast, Orkla) to mid-market wineries (Chrysalis Vineyards, Swiftwater Cellars, Thornton Winery) and large agribusiness partners (Certis Belchim, VIDO). Revenue is not publicly disclosed and the company remains pre-scale, with 11-50 employees and growth funded primarily by government grants and a C$5M convertible debenture rather than traditional venture capital.

Short descriptiontext

Renaissance BioScience is a Vancouver-based biotech founded in 2013 that develops proprietary non-GMO and gene-edited yeast strains for food, beverage, agriculture, and specialty industrial applications, commercialized globally through licensing partners and wholly owned subsidiaries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersVancouver, Canada
HQ citystring
Vancouver
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
yeast bioengineering, wine fermentation, baking ingredients, biopesticide technology, bioplastic production
Industry5 codes
PRIMARYCRADAOAI
Cultures, Probiotics & Fermentation Ingredients (Starter Cultures, Yeast, Adjuncts)
SECONDARYAFAJAJAC
Beverage Fermentation Cultures (Beer, Wine, Cider, Kombucha, Fermented Soft Drinks)
Agriculture & Food Production/Food Ingredients & Additives/Cultures & Fermentation Ingredients (Starter Cultures, Probiotics, Yeast)
SECONDARYAFAJAJAD
Bakery & Baking Yeast (Fresh, Active Dry, Instant, Specialty Yeasts)
Agriculture & Food Production/Food Ingredients & Additives/Cultures & Fermentation Ingredients (Starter Cultures, Probiotics, Yeast)
SECONDARYHLAAAIAD
Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYEUAAAIAL
Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
NAICS code4 codes
  • Food Manufacturing311
  • Beverage and Tobacco Product Manufacturing312
  • Biological Product (except Diagnostic) Manufacturing325414
  • Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing3253
SIC code3 codes
  • Food And Kindred Products2000
  • Beverages2080
  • Biological Products, (No Disgnostic Substances)2836
Product category
Yeast Bioengineering and Fermentation Technology
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Technology Licensing
TypeLicensing Royalties
Description

Renaissance licenses its proprietary yeast technologies to global manufacturing and distribution partners. Partners receive exclusive rights to manufacture and sell products in specified regions in exchange for licensing fees and ongoing royalties. Examples include Angel Yeast (global wine/cider/beer), Orkla (Nordic/Eastern Europe acrylamide-reducing yeast), and Quercus Europe (Spain wine yeast).

renaissancebioscience.com
2Subsidiary Product Sales
TypeOne Time License
Description

Wholly owned subsidiaries (Renaissance Yeast, Renaissance Ingredients, Bright Brewers Yeast) commercialize products directly in certain markets. These subsidiaries handle global sales, marketing and technical support for specific product lines.

renaissancebioscience.com
3Government Grants and R&D Funding
TypeManaged Services
Description

Company receives non-repayable government contributions and research funding from organizations including NRC IRAP, Mitacs, and Genome BC to support R&D activities and platform development.

packworld.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Renaissance BioScience develops proprietary yeast strains and bioengineering platforms for food, beverage, agricultural and industrial applications. The company designs and commercializes H2S-preventing wine yeast strains, acrylamide-reducing baker's yeast, premium brewing yeasts, a yeast-derived virus-like particle platform for RNAi biopesticides, and renewable bioplastic building blocks. Products are sold via wholly-owned subsidiaries (Renaissance Yeast Inc., Renaissance Ingredients Inc., Bright Brewers Yeast Inc.) and global licensing partners including Angel Yeast, Orkla Food Ingredients, Kerry, Gusmer Enterprises and Quercus Europe.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Up to 95% reduction in acrylamide levels in baked goods, fried potato products and coffee
+4 more records
Product overview1 text field

Renaissance BioScience is a yeast technology company that has developed multiple platform technologies commercialized through wholly owned subsidiaries: Renaissance Ingredients Inc. (acrylamide-reducing baker's yeast - Acrylow), Renaissance Yeast Inc. (H2S-preventing wine yeasts - Vivace, Allegro, Andante, Maestoso, Brioso, Ossia Organic), and Bright Brewers Yeast Inc. (premium beer yeasts). The company also operates a yeast-derived VLP platform for RNAi biopesticides and is developing renewable bioplastics through a partnership with Biome Bioplastics. The core technology encompasses whole organism engineering (non-GMO classical breeding and adaptive evolution) and gene-targeted engineering (gene editing and molecular biology).

Product and service5 records
1Acrylamide-Reducing Yeast (Renaissance Ingredients)
CategoryFood Ingredients / Acrylamide Reduction
Description

Non-GMO baker's yeast strains that consume the amino acid asparagine during food processing, achieving up to 80–95% reduction in acrylamide levels in bread, toast, fried potato products, snacks, cereals and coffee. Licensed exclusively to Kerry as Acryleast and to Orkla Food Ingredients as Acrylow in European markets.

2H2S-Preventing Wine Yeast (Renaissance Yeast)
CategoryWine & Cider Yeast Strains
Description

Classically bred, non-GMO wine and cider yeast strains including Vivace, Allegro, Andante, Maestoso, Brioso (for Pinot Noir) and Ossia Organic variants. All strains prevent hydrogen sulfide formation during fermentation while preserving normal sulfur dioxide production, eliminating remediation costs and enabling fuller flavor expression for winemakers.

3Bright Brewers Yeast
CategoryBrewing Yeast Strains
Description

Selectively bred premium beer yeast strains delivering ideal characteristics for distinct beer styles. All strains prevent hydrogen sulfide formation and include hybrid strains capable of creating unique new beer styles, targeting craft brewers seeking consistent quality and distinctive flavor profiles.

4Yeast-derived VLP Platform for RNAi Biopesticides
CategoryAgricultural Biotechnology / Biopesticides
Description

Novel yeast-derived virus-like particle (VLP) platform for RNA interference biopesticides. The platform enables cost-effective dsRNA production and ambient-temperature storage, expanding RNAi pest control beyond chewing insects to fungicides, herbicides and non-chewing insects. Delivered 98% mortality of Colorado potato beetle in independent testing.

5Renewable Bioplastics Technology
CategoryIndustrial Biotechnology / Bioplastics
Description

Sustainable bioplastic building blocks developed through yeast and bacterial fermentation processes. Targets packaging, personal care, health and consumer goods applications as renewable replacements for petroleum-derived materials. Co-developed with Biome Bioplastics Limited under a two-year collaboration supported by Canada's NRC IRAP and UK's Innovate UK.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2025-11-18
Description

Two-year collaboration valued at up to C$1.5 million to develop sustainable bioplastic building blocks using yeast and bacterial fermentation. Project supported by Canada's NRC IRAP and UK's Innovate UK. Targets packaging, personal care, health and consumer goods applications with goal to replace petroleum-derived materials.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2024-01-31
Description

Partnership for innovative development in animal health using yeast-based technologies.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2023-11-02
Description

Partnership for innovative biopesticide development. Certis Belchim is a leading provider of biological crop protection solutions.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2018-12-01
Description

Kerry commercialized Renaissance's acrylamide-reducing yeast technology as Acryleast, gaining organic suitable status in EU. Kerry is a major global taste and nutrition company that integrated the technology into its food ingredient portfolio.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2018-01-18
Description

Angel Yeast, a Shanghai Stock Exchange listed company (SSE:600298), signed a global license agreement to exclusively manufacture and supply Renaissance's yeast portfolio for wine, cider and craft beer industries worldwide starting Q4/2017. Angel Yeast has production facilities in China, Egypt and Russia and serves customers in more than 140 countries with over 5,000 employees.

6Orkla Food Ingredients
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2017-05-01
Description

Orkla Food Ingredients holds exclusive license to manufacture and sell Renaissance's acrylamide-reducing yeast (Acrylow) in Nordic and Baltic markets, later expanded to include Poland, Czech Republic and Slovakia. Product launched in Q3/2017 with excellent trial results showing 50-95% acrylamide reduction depending on application.

renaissancebioscience.com
Strategic tierRegionalTypeChannel Partner/ Reseller/ DistributorAnnounced on2015-01-01
Description

Gusmer Enterprises serves as exclusive distributor for Renaissance H2S-preventing wine yeasts for wine and cider in Canada and USA. Gusmer has extensive network of technical sales reps and strong reputation in the beverage industry.

Strategic tierRegionalTypeChannel Partner/ Reseller/ DistributorAnnounced on2015-01-01
Description

Multi-year agreement appointing Quercus Europe as exclusive distributor in Spain for Renaissance H2S-preventing conventional and organic wine and cider yeast strains.

9University of California, Davis
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2014-01-07
Description

Exclusive global license from UC Davis for patented H2S-preventing yeast technology invented by Dr. Linda Bisson. Technology developed through five years of commercial field testing. All Renaissance wine yeasts are based on this licensed technology.

renaissancebioscience.com
Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Lallemand
TypeDirect peer
Description

Lallemand is one of the world's largest privately held yeast producers, with a portfolio spanning wine, beer, baking, and distilling yeasts as well as yeast-based biopesticides and probiotics. It is the closest direct competitor to Renaissance BioScience's wine, beer, and bakery yeast product lines, with comparable customer base among food and beverage manufacturers.

TypeDirect peer
Description

Lesaffre is the world's largest yeast producer, offering baking, brewing, wine, and specialty yeast ingredients under brands such as Saf-instant and Fermentis. It is a direct competitor across virtually every fermentation ingredient category Renaissance addresses.

TypeDirect peer
Description

AB Mauri is the bakery ingredients division of Associated British Foods (FTSE 100) and a global supplier of baker's yeast, dough conditioners, and bakery improvers. It is a direct competitor in the acrylamide-reducing and baking yeast categories, and Renaissance's CBDO Dr. O'Cleirigh previously led business development at AB Mauri.

TypeDirect peer
Description

Novonesis (formed by the merger of Chr. Hansen and Novozymes) is a global bioscience company specializing in cultures, enzymes, and probiotics for food and beverage manufacturers. It overlaps directly with Renaissance's cultures, fermentation ingredients, and probiotic yeast initiatives targeting food and human wellness customers.

TypeDirect peer
Description

Angel Yeast (Shanghai Stock Exchange: 600298) is one of the world's largest yeast producers and is Renaissance's exclusive global manufacturing/distribution partner for wine, cider, and craft beer yeasts. It is both a key channel partner and a competitor with its own branded yeast portfolio across baking, brewing, and animal nutrition.

TypeBroad incumbent
Description

Kerry Group is a global taste and nutrition company (NYSE: KRYAY) that commercializes Renaissance's acrylamide-reducing yeast (Acryleast) under an exclusive license. While a critical commercial partner, Kerry's broader portfolio of food ingredients, flavors, and functional solutions places it as a large incumbent that could internalize or compete with adjacent Renaissance technologies.

TypeBroad incumbent
Description

DSM-Firmenich is a large global ingredients and bioscience company with a yeast-derived platform spanning food, beverage, animal nutrition, and personal care. It represents the broader incumbent archetype that Renaissance competes against for major food and beverage manufacturer accounts and for industrial biotech partnerships.

TypeEmerging player
Description

GreenLight Biosciences is a US-based RNA-focused biotech developing dsRNA-based biopesticides. It is the most direct emerging competitor to Renaissance's yeast-derived VLP RNAi biopesticide platform, particularly in the Colorado potato beetle and broader agricultural pest control market.

TypeEmerging player
Description

Benson Hill is a US-based food tech company using AI-driven genomics and proprietary platforms to develop improved plant-based food and feed ingredients. It is comparable to Renaissance as a smaller, platform-based biotech applying synthetic biology to the food and ingredient value chain.

TypeEmerging player
Description

Amyris is a synthetic biology company that engineered yeast strains to produce specialty ingredients (squalane, flavors, fragrances). It is comparable to Renaissance as a yeast-engineering platform targeting flavors, fragrances, biofuels, and bioplastics, and serves as a cautionary reference point on the capital intensity of scaling synthetic biology ingredients businesses.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Renaissance BioScience

Yeast Bioengineering and Fermentation Technologyrenaissancebioscience.com

Renaissance BioScience is a Vancouver-based biotech founded in 2013 that develops proprietary non-GMO and gene-edited yeast strains for food, beverage, agriculture, and specialty industrial applications, commercialized globally through licensing partners and wholly owned subsidiaries.

What Renaissance BioScience does

Renaissance BioScience Corp. is a privately held Vancouver-based applied life sciences company founded in 2013 that develops proprietary yeast-based platform technologies for the food and beverage, agriculture, and specialty industrial markets. The company's core technology stack combines whole organism engineering (non-GMO classical breeding and adaptive evolution) with gene-targeted engineering (gene editing and molecular biology), and an integrated design layer that produces yeast strains unachievable through either approach alone. Commercial product lines include acrylamide-reducing baker's yeast (Acrylow/Acryleast, reducing acrylamide by up to 95%), H2S-preventing wine yeast strains (Vivace, Allegro, Andante, Maestoso, Brioso, Ossia Organic), selectively bred premium beer yeasts under the Bright Brewers Yeast subsidiary, a yeast-derived virus-like particle (VLP) platform for RNAi biopesticides, and a renewable bioplastics program in partnership with Biome Bioplastics.

Renaissance operates a licensing-led go-to-market model. The company monetizes its strains primarily through exclusive regional and global license agreements with major industry manufacturers and distributors — Angel Yeast for global wine, cider and craft beer; Orkla Food Ingredients for acrylamide-reducing yeast in Nordic, Baltic and Eastern European markets; Kerry for global food ingredients; Gusmer Enterprises for North America; and Quercus Europe for Spain — supplemented by direct sales through three wholly owned subsidiaries (Renaissance Yeast Inc., Renaissance Ingredients Inc., Bright Brewers Yeast Inc.) and non-dilutive R&D funding from Canadian and UK government programs including NRC IRAP, Mitacs, Genome BC, and Innovate UK. The company holds 16 patents on H2S-preventing yeast across major wine-producing jurisdictions plus granted patents on RNA production and delivery in China, Australia, and Mexico, with multiple provisional and PCT filings on acrylamide reduction and the VLP platform.

Commercially, Renaissance has product-market fit in three distinct verticals: food and beverage (acrylamide reduction for baked goods, snacks and coffee; H2S prevention in wine; quality and consistency in craft beer); agricultural technology (RNAi biopesticides for Colorado potato beetle, canola flea beetle, and a broader fungicide/herbicide roadmap); and emerging specialty markets including bioplastics and plant-based protein flavor solutions. Customers range from global ingredient majors (Kerry, Angel Yeast, Orkla) to mid-market wineries (Chrysalis Vineyards, Swiftwater Cellars, Thornton Winery) and large agribusiness partners (Certis Belchim, VIDO). Revenue is not publicly disclosed and the company remains pre-scale, with 11-50 employees and growth funded primarily by government grants and a C$5M convertible debenture rather than traditional venture capital.

Renaissance BioScience firmographics

Firmographics
Name
Renaissance BioScience
Legal name
Renaissance BioScience Corp.
Website
https://renaissancebioscience.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
Renaissance BioScience is a Vancouver-based biotech founded in 2013 that develops proprietary non-GMO and gene-edited yeast strains for food, beverage, agriculture, and specialty industrial applications, commercialized globally through licensing partners and wholly owned subsidiaries.
Ownership category
akta.pro rank

Renaissance BioScience industry classification

Industry
Product category
Yeast Bioengineering and Fermentation Technology
NAICS
Food Manufacturing (311), Beverage and Tobacco Product Manufacturing (312), Biological Product (except Diagnostic) Manufacturing (325414), Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing (3253)
SIC
Food And Kindred Products (2000), Beverages (2080), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYCRADAOAI
Cultures, Probiotics & Fermentation Ingredients (Starter Cultures, Yeast, Adjuncts)
SECONDARYAFAJAJAC
Beverage Fermentation Cultures (Beer, Wine, Cider, Kombucha, Fermented Soft Drinks)
Agriculture & Food Production/Food Ingredients & Additives/Cultures & Fermentation Ingredients (Starter Cultures, Probiotics, Yeast)
SECONDARYAFAJAJAD
Bakery & Baking Yeast (Fresh, Active Dry, Instant, Specialty Yeasts)
Agriculture & Food Production/Food Ingredients & Additives/Cultures & Fermentation Ingredients (Starter Cultures, Probiotics, Yeast)
SECONDARYHLAAAIAD
Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYEUAAAIAL
Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)

Keywords

  • Yeast bioengineering
  • Wine fermentation
  • Baking ingredients
  • Biopesticide technology
  • Bioplastic production

Where Renaissance BioScience is headquartered

Location

Headquarters

HQ city
Vancouver
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Renaissance BioScience business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Technology Licensing: Renaissance licenses its proprietary yeast technologies to global manufacturing and distribution partners. Partners receive exclusive rights to manufacture and sell products in specified regions in exchange for licensing fees and ongoing royalties. Examples include Angel Yeast (global wine/cider/beer), Orkla (Nordic/Eastern Europe acrylamide-reducing yeast), and Quercus Europe (Spain wine yeast).
  2. Subsidiary Product Sales: Wholly owned subsidiaries (Renaissance Yeast, Renaissance Ingredients, Bright Brewers Yeast) commercialize products directly in certain markets. These subsidiaries handle global sales, marketing and technical support for specific product lines.
  3. Government Grants and R&D Funding: Company receives non-repayable government contributions and research funding from organizations including NRC IRAP, Mitacs, and Genome BC to support R&D activities and platform development.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

Renaissance BioScience product offering

Product offering

Core offering

Renaissance BioScience develops proprietary yeast strains and bioengineering platforms for food, beverage, agricultural and industrial applications. The company designs and commercializes H2S-preventing wine yeast strains, acrylamide-reducing baker's yeast, premium brewing yeasts, a yeast-derived virus-like particle platform for RNAi biopesticides, and renewable bioplastic building blocks. Products are sold via wholly-owned subsidiaries (Renaissance Yeast Inc., Renaissance Ingredients Inc., Bright Brewers Yeast Inc.) and global licensing partners including Angel Yeast, Orkla Food Ingredients, Kerry, Gusmer Enterprises and Quercus Europe.

Product overview

Renaissance BioScience is a yeast technology company that has developed multiple platform technologies commercialized through wholly owned subsidiaries: Renaissance Ingredients Inc. (acrylamide-reducing baker's yeast - Acrylow), Renaissance Yeast Inc. (H2S-preventing wine yeasts - Vivace, Allegro, Andante, Maestoso, Brioso, Ossia Organic), and Bright Brewers Yeast Inc. (premium beer yeasts). The company also operates a yeast-derived VLP platform for RNAi biopesticides and is developing renewable bioplastics through a partnership with Biome Bioplastics. The core technology encompasses whole organism engineering (non-GMO classical breeding and adaptive evolution) and gene-targeted engineering (gene editing and molecular biology).

Differentiator

Problem solved

Functional benefit

Products and services

  • Acrylamide-Reducing Yeast (Renaissance Ingredients) Non-GMO baker's yeast strains that consume the amino acid asparagine during food processing, achieving up to 80–95% reduction in acrylamide levels in bread, toast, fried potato products, snacks, cereals and coffee. Licensed exclusively to Kerry as Acryleast and to Orkla Food Ingredients as Acrylow in European markets.
  • H2S-Preventing Wine Yeast (Renaissance Yeast) Classically bred, non-GMO wine and cider yeast strains including Vivace, Allegro, Andante, Maestoso, Brioso (for Pinot Noir) and Ossia Organic variants. All strains prevent hydrogen sulfide formation during fermentation while preserving normal sulfur dioxide production, eliminating remediation costs and enabling fuller flavor expression for winemakers.
  • Bright Brewers Yeast Selectively bred premium beer yeast strains delivering ideal characteristics for distinct beer styles. All strains prevent hydrogen sulfide formation and include hybrid strains capable of creating unique new beer styles, targeting craft brewers seeking consistent quality and distinctive flavor profiles.
  • Yeast-derived VLP Platform for RNAi Biopesticides Novel yeast-derived virus-like particle (VLP) platform for RNA interference biopesticides. The platform enables cost-effective dsRNA production and ambient-temperature storage, expanding RNAi pest control beyond chewing insects to fungicides, herbicides and non-chewing insects. Delivered 98% mortality of Colorado potato beetle in independent testing.
  • Renewable Bioplastics Technology Sustainable bioplastic building blocks developed through yeast and bacterial fermentation processes. Targets packaging, personal care, health and consumer goods applications as renewable replacements for petroleum-derived materials. Co-developed with Biome Bioplastics Limited under a two-year collaboration supported by Canada's NRC IRAP and UK's Innovate UK.

Quantifiable outcome

  • Up to 95% reduction in acrylamide levels in baked goods, fried potato products and coffee
  • +4 more outcomes

Companies that use Renaissance BioScience

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Renaissance BioScience technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Renaissance BioScience partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered strategic, core and regional.

  • Biome Bioplastics LimitedstrategicStrategic or Co-development Partner · 18 November 2025Two-year collaboration valued at up to C$1.5 million to develop sustainable bioplastic building blocks using yeast and bacterial fermentation. Project supported by Canada's NRC IRAP and UK's Innovate UK. Targets packaging, personal care, health and consumer goods applications with goal to replace petroleum-derived materials.
  • Vaccine and Infectious Disease Organization (VIDO)strategicStrategic or Co-development Partner · 31 January 2024Partnership for innovative development in animal health using yeast-based technologies.
  • Certis BelchimstrategicStrategic or Co-development Partner · 2 November 2023Partnership for innovative biopesticide development. Certis Belchim is a leading provider of biological crop protection solutions.
  • KerrycoreChannel Partner/ Reseller/ Distributor · 1 December 2018Kerry commercialized Renaissance's acrylamide-reducing yeast technology as Acryleast, gaining organic suitable status in EU. Kerry is a major global taste and nutrition company that integrated the technology into its food ingredient portfolio.
  • Angel Yeast Co., Ltd.coreChannel Partner/ Reseller/ Distributor · 18 January 2018Angel Yeast, a Shanghai Stock Exchange listed company (SSE:600298), signed a global license agreement to exclusively manufacture and supply Renaissance's yeast portfolio for wine, cider and craft beer industries worldwide starting Q4/2017. Angel Yeast has production facilities in China, Egypt and Russia and serves customers in more than 140 countries with over 5,000 employees.
  • Orkla Food IngredientscoreChannel Partner/ Reseller/ Distributor · 1 May 2017Orkla Food Ingredients holds exclusive license to manufacture and sell Renaissance's acrylamide-reducing yeast (Acrylow) in Nordic and Baltic markets, later expanded to include Poland, Czech Republic and Slovakia. Product launched in Q3/2017 with excellent trial results showing 50-95% acrylamide reduction depending on application.
  • Gusmer EnterprisesregionalChannel Partner/ Reseller/ Distributor · 1 January 2015Gusmer Enterprises serves as exclusive distributor for Renaissance H2S-preventing wine yeasts for wine and cider in Canada and USA. Gusmer has extensive network of technical sales reps and strong reputation in the beverage industry.
  • Quercus Europe, S.L.regionalChannel Partner/ Reseller/ Distributor · 1 January 2015Multi-year agreement appointing Quercus Europe as exclusive distributor in Spain for Renaissance H2S-preventing conventional and organic wine and cider yeast strains.
  • University of California, DaviscoreTechnology or Integration · 7 January 2014Exclusive global license from UC Davis for patented H2S-preventing yeast technology invented by Dr. Linda Bisson. Technology developed through five years of commercial field testing. All Renaissance wine yeasts are based on this licensed technology.

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Renaissance BioScience competitors and assessment

Company assessment

Direct peers

  • Lallemand: Lallemand is one of the world's largest privately held yeast producers, with a portfolio spanning wine, beer, baking, and distilling yeasts as well as yeast-based biopesticides and probiotics. It is the closest direct competitor to Renaissance BioScience's wine, beer, and bakery yeast product lines, with comparable customer base among food and beverage manufacturers.
  • Lesaffre: Lesaffre is the world's largest yeast producer, offering baking, brewing, wine, and specialty yeast ingredients under brands such as Saf-instant and Fermentis. It is a direct competitor across virtually every fermentation ingredient category Renaissance addresses.
  • AB Mauri: AB Mauri is the bakery ingredients division of Associated British Foods (FTSE 100) and a global supplier of baker's yeast, dough conditioners, and bakery improvers. It is a direct competitor in the acrylamide-reducing and baking yeast categories, and Renaissance's CBDO Dr. O'Cleirigh previously led business development at AB Mauri.
  • Novonesis (Chr. Hansen): Novonesis (formed by the merger of Chr. Hansen and Novozymes) is a global bioscience company specializing in cultures, enzymes, and probiotics for food and beverage manufacturers. It overlaps directly with Renaissance's cultures, fermentation ingredients, and probiotic yeast initiatives targeting food and human wellness customers.
  • Angel Yeast: Angel Yeast (Shanghai Stock Exchange: 600298) is one of the world's largest yeast producers and is Renaissance's exclusive global manufacturing/distribution partner for wine, cider, and craft beer yeasts. It is both a key channel partner and a competitor with its own branded yeast portfolio across baking, brewing, and animal nutrition.

Broad incumbents

  • Kerry Group: Kerry Group is a global taste and nutrition company (NYSE: KRYAY) that commercializes Renaissance's acrylamide-reducing yeast (Acryleast) under an exclusive license. While a critical commercial partner, Kerry's broader portfolio of food ingredients, flavors, and functional solutions places it as a large incumbent that could internalize or compete with adjacent Renaissance technologies.
  • DSM-Firmenich: DSM-Firmenich is a large global ingredients and bioscience company with a yeast-derived platform spanning food, beverage, animal nutrition, and personal care. It represents the broader incumbent archetype that Renaissance competes against for major food and beverage manufacturer accounts and for industrial biotech partnerships.

Emerging players

  • GreenLight Biosciences: GreenLight Biosciences is a US-based RNA-focused biotech developing dsRNA-based biopesticides. It is the most direct emerging competitor to Renaissance's yeast-derived VLP RNAi biopesticide platform, particularly in the Colorado potato beetle and broader agricultural pest control market.
  • Benson Hill: Benson Hill is a US-based food tech company using AI-driven genomics and proprietary platforms to develop improved plant-based food and feed ingredients. It is comparable to Renaissance as a smaller, platform-based biotech applying synthetic biology to the food and ingredient value chain.
  • Amyris: Amyris is a synthetic biology company that engineered yeast strains to produce specialty ingredients (squalane, flavors, fragrances). It is comparable to Renaissance as a yeast-engineering platform targeting flavors, fragrances, biofuels, and bioplastics, and serves as a cautionary reference point on the capital intensity of scaling synthetic biology ingredients businesses.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Renaissance BioScience financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Renaissance BioScience leadership team

Management profile

Number of profiles

Profiles7 records

Renaissance BioScience subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Renaissance BioScience funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Renaissance BioScience M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Renaissance BioScience

What does Renaissance BioScience do?

Renaissance BioScience develops proprietary yeast strains and bioengineering platforms for food, beverage, agricultural and industrial applications. The company designs and commercializes H2S-preventing wine yeast strains, acrylamide-reducing baker's yeast, premium brewing yeasts, a yeast-derived virus-like particle platform for RNAi biopesticides, and renewable bioplastic building blocks. Products are sold via wholly-owned subsidiaries (Renaissance Yeast Inc., Renaissance Ingredients Inc., Bright Brewers Yeast Inc.) and global licensing partners including Angel Yeast, Orkla Food Ingredients, Kerry, Gusmer Enterprises and Quercus Europe.

Is Renaissance BioScience a public or private company?

Renaissance BioScience is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Renaissance BioScience founded?

Renaissance BioScience was founded in 2013. It employs 11 to 50 people.

Where is Renaissance BioScience based?

Renaissance BioScience is headquartered in Vancouver, Canada, in the North America region.

How does Renaissance BioScience make money?

Three revenue lines are on record. Technology Licensing is the primary driver. The others are subsidiary Product Sales and government Grants and R&D Funding.

Who are Renaissance BioScience's main competitors?

Direct peers on record are Lallemand, Lesaffre, AB Mauri, Novonesis (Chr. Hansen) and Angel Yeast. Broad incumbents are Kerry Group and DSM-Firmenich. Emerging players are GreenLight Biosciences, Benson Hill and Amyris.

Does Renaissance BioScience have an API?

No public API is recorded for Renaissance BioScience.

What industry is Renaissance BioScience in?

Renaissance BioScience's product category is Yeast Bioengineering and Fermentation Technology. Its primary akta.pro industry code is CRADAOAI, Cultures, Probiotics & Fermentation Ingredients (Starter Cultures, Yeast, Adjuncts), with a secondary code of AFAJAJAC, Beverage Fermentation Cultures (Beer, Wine, Cider, Kombucha, Fermented Soft Drinks). Its NAICS code is 311 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
National Hog FarmerRenaissance BioScience, VIDO target two global pig diseasesRenaissance BioScience has partnered with the Vaccine and Infectious Disease Organization (VIDO) to develop yeast-based vaccines and health solutions for pigs, supported by a $600,000 grant from the Saskatchewan Agricultural Development Fund. The collaboration targets porcine epidemic diarrheal virus and porcine reproductive and respiratory syndrome virus, alongside initiatives to improve piglet gut health and reduce antibiotic use.TechcouverRenaissance Wages War on Wireworms in New Challenge for Targeted BiotechRenaissance BioScience, a Vancouver-based yeast bioengineering company, is developing an RNAi bio-pesticide to target wireworms, soil-dwelling larvae of click beetles that cause severe damage to crops including potatoes, root vegetables, corn, and cereals. The project, funded by Genome BC, represents a significant new application for the company's existing yeast-based RNAi platform originally focused on above-ground insect pests. If successful, the technology could be extended to address an entirely new category of below-ground agricultural pests, greatly expanding the company's market opportunities.AdvfnADVFNThe article reports on developments in the agricultural biotechnology and biologicals sector, including funding for Renaissance BioScience, patent activity of major agrochemical companies, and advancements in RNAi crop protection technology. It highlights strategic focus areas like biologicals, hybrid wheat, and novel delivery systems for crop protection products.AgriBusiness GlobalRenaissance BioScience Receives Genome BC Funding to Extend RNAi Biopesticide Platform to Target Soil-Dwelling Crop PestsRenaissance BioScience Corp. has received Genome BC funding to extend its yeast-based RNA interference (RNAi) biopesticide technology from above-ground insect pests to target soil-dwelling wireworms, representing a new technical challenge for the company. The project aims to develop a precision biopesticide targeting Agriotes species of wireworms, which cause substantial crop losses in Europe, North America, and other key agricultural markets. If successful, this would significantly expand the range of insect targets and crop protection applications for RNAi biopesticides, opening doors to controlling an entirely new category of agricultural pests.FinancialContent Business PageRenaissance BioScience Receives Genome BC Funding to Extend RNAi Biopesticide Platform to Target Soil-Dwelling Crop PestsRenaissance BioScience has received funding from Genome BC to develop a yeast-based RNA interference (RNAi) biopesticide targeting wireworms, destructive soil-dwelling larvae that damage economically important crops globally including potatoes, root vegetables, corn, and cereals. The project represents the company's first effort to adapt its RNAi technology for below-ground pest control, a technical challenge that, if successful, could significantly expand the number of insect targets and crop protection applications. Success with this project could establish the foundation for future RNAi products targeting a broad range of soil-dwelling insects while supporting demand for environmentally sustainable alternatives to conventional chemical pesticides.24-7 Press ReleaseRenaissance BioScience Receives Genome BC Funding to Extend RNAi Biopesticide Platform to Target Soil-Dwelling Crop PestsRenaissance BioScience Corp. announced a new Genome BC funded project to extend its yeast-based RNA interference (RNAi) biopesticide technology from above-ground insect pests to target soil-dwelling crop pests, beginning with wireworms. The project aims to develop a precision biopesticide targeting Agriotes species of wireworms, which cause substantial crop losses in Europe, North America, and other key agricultural markets. If successful, the technology could significantly expand the range of insect targets and crop protection applications for RNAi biopesticides, opening opportunities across multiple crops and agricultural markets.TechcouverLocal Research Targets Innovation at Intersection of Biotech and AgricultureGenome British Columbia is funding three research projects to develop biotech tools for protecting the province's fruit and vegetable crops, which export more than $1 billion annually. The projects include developing diagnostic qPCR tests for plant-parasitic nematodes, a natural biopesticide using RNA interference for wireworms, and improved PCR diagnostics for fruit crop pathogens. Researchers from Kwantlen Polytechnic University, the BC Ministry of Agriculture and Food, Agriculture and Agri-Food Canada, and Renaissance Bioscience are collaborating on these initiatives to address longstanding pest and disease challenges facing BC growers.AgFunderNewsRenaissance Bioscience unveils yeast-derived VLP platform for next-gen RNAi biopesticidesRenaissance Bioscience, a Vancouver-based biotech firm, has developed a novel yeast-derived virus-like particle (VLP) platform for RNA interference (RNAi) biopesticides that could significantly expand the scope of its existing technology beyond chewing insects to fungicides, herbicides, and non-chewing insects. The system repurposes naturally occurring dsRNA viruses inside yeast cells as protein nano-carriers roughly 40-50 nanometers in size, allowing cost-effective production and ambient-temperature storage of dsRNA payloads. The company has filed a provisional patent on the platform and is seeking partners for joint development agreements, with field trials of its first-generation Colorado potato beetle-targeting system already underway and the US identified as the likely first commercial market.EIN PresswireRenaissance BioScience Files Patent Application for Advanced Yeast-derived VLP RNA Delivery TechnologyRenaissance BioScience filed a provisional patent application for yeast-derived virus-like particle (VLP) technology for RNA production and delivery. The VLPs are non-infectious, nanoscale structures that expand applications beyond RNAi-based biopesticides to include biocontrol, fungicides, herbicides, and therapeutic delivery. The company invites industrial inquiries for collaboration.